Status:
COMPLETED
Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye
Lead Sponsor:
Alcon Research
Conditions:
Dry Eye
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to see if Rimexolone (FID 109980) is a safe and effective treatment of dry eye.
Eligibility Criteria
Inclusion
- documented dry eye history
- ocular symptoms
- tear use
- dry eye ocular signs
Exclusion
- Under 18
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2007
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00471419
Start Date
July 1 2006
End Date
August 1 2007
Last Update
June 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland
Cleveland, Ohio, United States, 44115